Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sinopharm Group Co Ltd
SWB:X2S
Sinopharm Group Co Ltd
SWB:X2S
Price:
1.8125
EUR
2.84%
Market Cap:
€5.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sinopharm Group Co Ltd
SWB:X2S
|
CN |
|
N
|
NetEase Inc
BMV:NTESN
|
CN |
|
R
|
Recruit Holdings Co Ltd
SWB:1RH
|
JP |
|
Tharisa PLC
F:7YZ
|
CY |
|
S
|
Sanofi SA
SWB:SNW2
|
FR |
|
N
|
Nexon Co Ltd
F:7NX
|
JP |
|
G
|
G8 Education Ltd
F:3EAG
|
AU |
|
D
|
Defiance Silver Corp
OTC:DNCVF
|
CA |
|
Wisdom Marine Lines Co Ltd
TWSE:2637
|
TW |
|
D
|
Desert Control AS
OSE:DSRT
|
NO |
|
M
|
McKesson Corp
DUS:MCK
|
US |
|
D
|
Darden Restaurants Inc
DUS:DDN
|
US |
|
T
|
thyssenkrupp AG
DUS:TKA
|
DE |
|
E
|
eBay Inc
SWB:EBA
|
US |
|
Orege SA
F:4ZF
|
FR |
|
TAL Education Group
NYSE:TAL
|
CN |
Wall St Price Targets
X2S Price Forecast
Based on 15 analysts
Based on 15 analysts
+32% Upside
from
€1.8125
today
Sinopharm Group Co Ltd (X2S)’s 12-month stock price forecast through August 2027 has a consensus target of €2.3851, implying 32% upside. The forecast is based on price targets from 15 Wall Street analysts.
X2S Analyst Rating
No ratings yet
No ratings yet
Sinopharm Group Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
2.3851
EUR
2.3851
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 2.3851 EUR with a low forecast of 1.9027 EUR and a high forecast of 3.1382 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 7%.